Abstract: An inspection system (100) for inspecting a lighting device (150) during an assembly process of the lighting device; wherein the lighting device comprises a base plate (153) and a plurality of components (155) mounted on the base plate; wherein the inspection system comprises: a light source (120) arranged for illuminating the lighting device according to a first light output spectrum for providing a luminance contrast between the base plate and the plurality of components; an imaging unit/camera (130) arranged for capturing a first image of the illuminated lighting device; a controller (110) comprising a processing unit for determining a luminance contrast measure of the captured first image; wherein the processing unit is further arranged for, when the luminance contrast measure of the captured first image exceeds a threshold value, adapting the first light output spectrum, and wherein the imaging unit is further arranged for capturing a second image of the lighting device illuminated according to the adapt

Abstract: A computing device is configured to: obtain information of tracking areas including a first and second tracking area, the first tracking area comprising first cells and the second tracking area comprising second cells; generate a user interface with a visualization of the tracking areas, the user interface comprising first cell user interface elements visually representing the first cells and second cell user interface elements visually representing the second cells; output the user interface for display at a display device; receive user input indicative of filtering criteria; generate a modified user interface by modifying at least one of the first cell user interface elements or the second user interface elements to visually indicate the first tracking area satisfies the filtering criteria and the second tracking area does not satisfy the filtering criteria; and output the modified user interface for display at the display device.

Abstract: An exemplary method of imaging tissue of a subject using a rolling shutter imager to provide a video stream comprises: sequentially resetting a plurality of rows of pixels of the rolling shutter imager from a first row to a last row; transitioning a liquid crystal shutter from a closed state to an open state; after the liquid crystal shutter is transitioned into the open state and after resetting the last row, illuminating the tissue of the subject with an illumination light for an illumination period to accumulate charge at the plurality of rows of pixels, and after the illumination period ends, sequentially reading the accumulated charge at the rows of pixels from the first row to the last row; generating an image frame from the sequentially read accumulated charge at the plurality of rows of pixels; and adding the image frame to the video stream.

Abstract: A system is disclosed for monitoring pollination of plants carrying one or more flowers. The system comprises a plurality of microphones for monitoring an area comprising said one or more flowers. Each microphone out of the plurality of microphones is configured to monitor a sub-area of the monitored area. Further, each microphone is suitable for recording sounds produced by a pollinator, such as a bumblebee, that is present in the microphone's sub-area and is configured to output one or more signals indicative of recorded sounds. The system further comprises a data processing system that is configured to receive, from each of the plurality of microphones, said one or more signals indicative of recorded sounds. The data processing system is further configured to determine, based on the signals received from the plurality of microphones, a value of a pollination quality parameter indicative of how well one or more flowers in the monitored area are pollinated.

Abstract: The present invention relates to a conjugate having the formula (1): wherein a receptor binding molecule (RBM) is connected with a drug moiety (D), the conjugate comprising a phosphorus(V) moiety. The present invention also relates to intermediates for producing the same, methods of preparing the same, pharmaceutical compositions comprising the same, as well as uses thereof.

Abstract: A composition and a method for preparing a polymer composite article. The composition comprises (A) a filler in an amount of from 10 to 90 wt. %. The composition also comprises (B) a polymer in an amount of from 10 to 90 wt. %, wherein the (B) polymer comprises a polyvinyl. Further, the composition comprises (C) an organopolysiloxane in an amount of from greater than 0 to 10 wt. %; the (C) organopolysiloxane having at least one silicon-bonded hydroxyl group and a viscosity of from 1,000 to 60,000 mPa·s at 25° C. The ranges for components (A)-(C) are based on the total weight of components (A), (B) and (C) in the composition.

Abstract: The present technology relates to a coating material comprising at least one branched or linear unsaturated aliphatic hydrocarbon having from 10 to 50 carbon atoms and having at least one carbon-carbon double or triple bond for use in electrochemical applications, particularly in electrochemical accumulators such as all-solid-state batteries. The present technology also relates to coated particles comprising said coating material and processes of manufacturing the same. Also described are electrode materials, electrodes, electrolytes, current collector coating materials and current collectors comprising said coated particles and their use in electrochemical cells, for example, in electrochemical accumulators, particularly in all-solid-state batteries.

Abstract: A composition contains a silylated polysaccharide, where the silylated polysaccharide is characterized by: (a) having linked fructose, galactose, anhydrogalactose, or glucose saccharide units provided that glycosidic linkages of glucose are alpha linkages and that the silylated polysaccharide is other than a silylated starch; and (b) on average 1 to 100 mole-percent of the hydroxyl groups on the polysaccharide have been silylated with a silyl group having the structure —SiR3 linked to the polysaccharide through a C—O—Si bond where each R is independently selected from hydrocarbyl radicals having from one to 12 carbon atoms, provided that on average at least one R per polysaccharide has a terminally unsaturated carbon-carbon double bond.

Abstract: A deck for holding a cosmetic product, the deck including a rigid outer rim including one or more securing points for securing the outer rim to a container and a flexible inner portion connected to the rigid outer rim, the flexible inner portion including a well for suspending a cosmetic product.

Abstract: Provided is a method for a Hardware Security Module (HSM) appliance to provide cryptographic services to multiple clients via cryptographic service requests and responses transmitted over a secure communication channel there between. The method comprises the steps of providing a traffic control feature for communications over said secure communication channel by way of a Linux Kernel, and leveling cryptographic service and balancing a workload of cryptographic transactions on the HSM appliance for the multiple clients submitting said requests and receiving said responses by way of a Traffic Control Agent (TCA), thereby distributing a fair, proportional share of resources on the HSM appliance needed for servicing the cryptographic services to multiple clients irrespective of thread count per client. Other embodiments disclosed, including a dynamic intelligent TCA.

Abstract: The present invention relates to combinations comprising a positive allosteric modulator (“PAM”) of metabotropic glutamatergic receptor subtype 2 (“mGluR2”) or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic receptor subtype 2 compound or a pharmaceutically acceptable salt or a solvate thereof, and a synaptic vesicle protein 2A (“SV2A”) ligand.

Abstract: The present invention relates to novel anti-TPBG antibody comprising Fc silencing mutations such as leucine (L) to alanine (A) substitution at the position 234 and 235 (LALA mutations), antibody-drug-conjugates (ADCs) based thereon as well as to therapeutic methods and uses thereof, particularly in relation to cancer treatment.

Abstract: A concrete block includes a dry cast concrete body having opposite first and second sides, opposite first and second end faces extending between the first and second sides, and opposite first and second bearing faces extending between the first and second sides and the first and second end faces. Each of the first and second bearing faces defines an inset region sized to receive a key that will also fit into the inset region of a like block stacked thereon. The body has at least a pair of rod-receiving apertures extending completely therethrough between the first and second sides to permit attachment to a like block through the first and second sides with a rod extending through each of the apertures. The block can be tapered to form curved walls.

Abstract: In one embodiment, a technique for providing absolute orientation of a mobile device involves aligning the orientation sensor of the mobile device with the Earth's coordinate system. An initial orientation from the orientation sensor of the mobile device is accessed, a user is prompted to move the mobile device in a direction of the initial orientation, and using a position sensor, a set of position information that describes positions of the mobile device is captured while the mobile device is being moved in the direction. Based on the set of position information, a vector of movement is determined. Using the vector of movement, an orientation difference is calculated between the Earth's coordinate system and a coordinate system of the mobile device. Upon demand, an absolute orientation of the mobile device may be produced by accessing a live orientation from the orientation sensor and adding the orientation difference.

Abstract: Modified coronaviras spike (S)-protein, virus-like particle (VLPs) comprising the modified S protein and nucleic acids encoding modified S protein are provided. Methods for modified S-protein and VLP production in a host or host cell are also described. The modified S-protein may comprise a transmembrane domain (TM) or portion of a TM, and a cytosolic tail (CT) or of a CT, wherein the CT or portion of the CT is derived from an influenza hemagglutinin (HA) protein and wherein the TM or portion of the TM is heterologous to the CT or portion of the CT. In addition a method for inducing immunity to a coronaviras infection in a subject, comprising administering a composition comprising the modified coronaviras (S)-protein or VLP to the subject is described.

Abstract: Techniques for enabling a library of local maps to remain de-coupled from a global map are disclosed. An MR system is determined to be located on a platform that is currently moving or that has an ability to readily move. That platform's type is determined. Based on the determined type for the platform, a 3D boundary that approximates a shape for the platform's type is generated. The 3D boundary is imposed on the platform. Scanning data for the platform is acquired. The bounds for that scanning data is at least initially limited to that of the 3D boundary. The scanning data is used to build or supplement a library of local maps. The library is representative of the platform. That library is prevented from being coupled to a global map.

Abstract: The invention provides a method for growing arthropods and photo-autotrophic organism in a shared water recipient (2000), wherein the method comprises: (a) monitoring an arthropod monitoring parameter of the arthropods in the shared water recipient, wherein the arthropod monitoring parameter is related to one or more of growth, metabolism, and behavior of the arthropods: and (b) controlling an photo-autotrophic organism control parameter of the photo-autotrophic organism in the shared water recipient in dependence of the arthropod monitoring parameter, wherein the photo-autotrophic organism control parameter influences one or more of growth and metabolism of the photo-autotrophic organisms.

Abstract: A system for processing and displaying medical imaging data onto an electronic display is configured to: access a plurality of data portions corresponding to a frame of the one or more video frames stored in memory; process the plurality of data portions using a single instruction multiple data (SIMD) processing architecture such that each data portion of the plurality of data portions is separately processed in parallel using one or more common instructions; and transmit the processed plurality of data portions to an electronic display; and a second processor, wherein the second processor is communicatively coupled to the first processor, and wherein the second processor is configured to coordinate one or more operations of the first processor.

Abstract: In example embodiments, techniques are provided for using machine learning to predict railroad track geometry exceedances to enable proactive maintenance. A machine learning model of a rail operational analytics application may be trained to directly output a probability of future railroad track geometry exceedances for each portion of track of a railroad. Training may be performed using all available railroad track data, and the task of selecting which data is relevant to predicting probability of railroad track geometry exceedances may be devolved to the machine learning model. Further, assumptions about the specific railroad and data characteristics may be avoided, providing the machine learning model flexibility, and allowing for dynamic changes in the problem formulation.

Abstract: Bioconjugates for mediating cytosolic/nuclear and/or intracellular delivery of a membrane impermeable cargo are described herein. The bioconjugates comprise one or more synthetic peptide shuttle agents conjugated in a cleavable or non-cleavable fashion to a linear or multi-armed biocompatible non-anionic hydrophilic polymer, which may optionally be further covalently linked to a cargo. Bioconjugation generally allows for usage at a higher shuttle agent or shuttle agent monomer concentration, usage at a broader effective concentration window, and/or improved performance for in vivo administrations (e.g., to target organs or tissues contacting or proximal to bodily fluids and/or secretions), as compared to a corresponding unconjugated shuttle agent.